Digestive care`s Biologic Pertzye (pancrelipase) Receives Approval in the U.S.
Vivus` Biologic Pancreaze (pancrelipase) Receives Approval in the U.S.
Viokase`s Biologic Viokace (pancrelipase) Receives Approval in the U.S.
Eurand`s Biologic Zenpep (pancrelipase) Receives Approval in the U.S.
NORTH CHICAGO, Ill., Oct. 24, 2022 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that 26 abstracts across its gastroenterology portfolio will be presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting, October 21-26, 2022, in Charlotte, N.C., and virtually.
Viokace's Biologic Viokace (Pancrelipase) Receives Approval in the U.S.
Eurand's Biologic Zenpep (Pancrelipase) Receives Approval in the U.S.
Digestive's Biologic Pertzye (Pancrelipase) Sodium Receives Approval in the U.S.
AbbVie`s Biologic Creon (Pancrelipase) Receives Approval in the U.S.